Your browser doesn't support javascript.
loading
The propositive study: Immunogenicity and safety of a four-component recombinant protein-based vaccine against MenB and a quadrivalent conjugate MenACWY vaccine in people living with HIV.
Isitt, Catherine; Bartolf, Angela; Andrews, Nick; Athaide, Shehnaz; Pryce-Williams, Richard; Townsend-Payne, Kelly; Borrow, Ray; Ladhani, Shamez; Heath, Paul T; Cosgrove, Catherine A.
  • Isitt C; Vaccine Institute, St. George's University of London & St George's University Hospital NHS Trust, London, UK.
  • Bartolf A; Vaccine Institute, St. George's University of London & St George's University Hospital NHS Trust, London, UK.
  • Andrews N; United Kingdom Health Security Agency, Colindale, UK.
  • Athaide S; Vaccine Institute, St. George's University of London & St George's University Hospital NHS Trust, London, UK.
  • Pryce-Williams R; United Kingdom Health Security Agency, Vaccine Evaluation Unit, Manchester, UK.
  • Townsend-Payne K; United Kingdom Health Security Agency, Vaccine Evaluation Unit, Manchester, UK.
  • Borrow R; United Kingdom Health Security Agency, Vaccine Evaluation Unit, Manchester, UK.
  • Ladhani S; United Kingdom Health Security Agency, Colindale, UK.
  • Heath PT; Centre for Neonatal and Paediatric Infection, St. George's University of London, London, UK.
  • Cosgrove CA; Vaccine Institute, St. George's University of London & St George's University Hospital NHS Trust, London, UK.
HIV Med ; 24(9): 979-989, 2023 09.
Article en En | MEDLINE | ID: mdl-37088964

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Vacunas Meningococicas / Infecciones Meningocócicas Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Vacunas Meningococicas / Infecciones Meningocócicas Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article